Latest Period
n/a
Security Snapshot
JAZZ PHARMACEUTICALS PLC - COM (JAZZ) Institutional Ownership
CUSIP: 472147107
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COM
- Symbol
- JAZZ on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- JAZZ - JAZZ PHARMACEUTICALS PLC - COM is tracked under CUSIP 472147107.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 0 to 1 between Q3 2023 and Q1 2024.
- Reported value moved from $0 to $14,450.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
472147107
Latest holder period
n/a
13F holders
13D/G owners
0
CIK / CUSIP context first
JAZZ full holder history
Jazz Pharmaceuticals plc SEC filings
Jazz Pharmaceuticals plc company facts
Jazz Pharmaceuticals plc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 472147107:
Institutional Holders of JAZZ PHARMACEUTICALS PLC - COM (JAZZ) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 120 | $14,450 | +$14,450 | $120.42 | 1 |
| 2023 Q3 | 0 | $0 | -$14,876 | 0 | |
| 2023 Q2 | 120 | $14,876 | -$204,619 | $123.97 | 1 |
| 2023 Q1 | 1,500 | $219,495 | $146.33 | 1 | |
| 2022 Q4 | 1,500 | $238,965 | +$238,965 | $159.31 | 1 |
| 2016 Q3 | 0 | $0 | -$5,051,000 | 0 | |
| 2016 Q2 | 35,751 | $5,051,000 | +$2,533,000 | $141.28 | 2 |
| 2016 Q1 | 19,289 | $2,518,000 | +$249,594 | $130.54 | 1 |
| 2015 Q4 | 17,377 | $2,443,000 | +$98,552 | $140.59 | 1 |
| 2015 Q3 | 16,676 | $2,215,000 | $132.83 | 1 | |
| 2015 Q2 | 16,676 | $2,936,000 | -$158,631 | $176.06 | 1 |
| 2015 Q1 | 17,577 | $3,037,000 | -$197,318 | $172.78 | 1 |
| 2014 Q4 | 18,719 | $3,065,000 | -$16,175,840 | $163.74 | 1 |
| 2014 Q3 | 119,837 | $19,240,840 | +$15,588,840 | $160.56 | 2 |
| 2014 Q2 | 24,845 | $3,652,000 | -$17,236,443 | $146.99 | 1 |
| 2014 Q1 | 149,187 | $20,689,386 | -$377,903 | $138.68 | 2 |